First Patients Treated in New Robotic Arrhythmia Care Program at Overland Park Regional Medical Center
Stereotaxis’ partnership with
RMN uses robotics and magnetic fields to navigate a cardiac catheter directly from the tip. The technology consists of two robotically controlled magnets placed next to the operating table. During the procedure, a physician uses a computer interface to adjust the magnetic field around the patient and precisely direct and steer this cardiac ablation catheter in the heart.
Dr. Dhanunjaya “DJ” Lakkireddy, Medical Director,
“The new cardiac arrhythmia labs at OPRMC were recently opened and are currently treating patients,” said Dr. Lakkireddy. “They represent the latest advances in the field of electrophysiology including robotic technology that enables improved outcomes and unparalleled safety for patients during cardiac ablation procedures. Robotics also allows OPRMC electrophysiologists to better address a range of complex arrhythmias that otherwise might not have been treated, providing hope to many patients who otherwise would have had no options for cardiac arrhythmia. We have observed the clinical value of robotic cardiac ablation and are excited to be providing patients convenient access to this technology.”
“As a world-renowned leader in electrophysiology research and patient care, Dr. Lakkireddy recognizes the significant patient, provider, and physician benefits of RMN.
This press release includes statements that may constitute "forward-looking" statements by
Chairman and Chief Executive Officer
Chief Financial Officer
Source: Stereotaxis, Inc.